Viatron Technologies비아트론
141000 · KOSDAQ · ₩141000 · 비아트론
What brokers say about Viatron Technologies
Calculated by JONBUR from publicly available broker reports. Reports belong to their publishers. Not financial advice. Includes brokers that publish research publicly; some brokers' reports are client-only and not included.
AI summary of public information
An AI summary of the public information on this company: filed financial statements, filings, prices and news headlines. It doesn't use broker reports; their targets and estimates are shown above.
Viatron swung to a trailing operating loss in H1 2026 even as its share price has risen sharply over the past year.
Viatron Technologies, a KOSDAQ-listed maker of display heat-treatment equipment, reported trailing-twelve-month revenue of ₩57.7B and an operating loss of about ₩0.6B to H1 2026, after a profitable 2025 with ₩65.1B revenue and ₩9.2B operating income. Trailing net income of ₩10.5B is well above operating income, and free cash flow was negative at about -₩9.0B. The share price closed at ₩11,420 on 2026-10-23, up 33.9% over one year.
What stands out
- Trailing operating margin is -1% versus 14.1% in 2025, while trailing net margin is 18.1%, so the reported profit is far from its operating result.
- Revenue has fallen from 2024's ₩58.0B peak level pattern only partly; 2025 revenue rose 12.2%, but 2024 growth of 107.2% followed a sharp 2023 drop.
- Filings show a run of major sales or supply contracts in 2026, including a recent ₩26.2B display manufacturing equipment contract reported by Edaily.
- Valuation is near its own history: P/E 13.2 and P/B 0.7, and the DCF base-case fair value is ₩6,277, below the current price, with bear ₩4,335 and bull ₩9,677.
- Peers such as Hanmi Semiconductor, Jusung Engineering and Rainbow Robotics trade at much higher multiples, so direct comparison is limited.
What to watch
- Whether the H1 2026 operating loss persists in the next filed quarterly or annual results, and the reason for the gap between operating and net income.
- Follow-up amendments to recent major contract filings, and whether contract revenue shows up in future financials.
- Negative free cash flow and the 20-day net selling by foreign and institutional investors, against retail buying.
Data as of Oct 23, 2026 · written 5d ago
This is not financial advice.
Also known as: Viatron Technologies / 비아트론 / 141000 / KRX:141000
Source: KRX statistical information